Genelabs Technologies, Inc.

Maxine B Yonker

Kenneth E Schwartz

Marc J Gurwith

Jagdish Parasrampuria

Disclosed are improved pharmaceutical formulations comprising dehydroepiandrosterone (DHEA), enriched in selected polymorphic forms, for therapeutic applications. In one embodiment, the formulation comprises, in solid form, DHEA, at least 85% of which is present as a single polymorph selected from the form I polymorph or the form II polymorph, and at least one pharmaceutical excipient. Methods for making and using such compositions are also disclosed.

Growing community of inventors

Emerald Hills, CA, United States of America

Maxine B Yonker